Phage Display and mRNA Display for Enzyme Engineering

inquiry

Creative Enzymes provides advanced display technologies—phage display and mRNA display—to accelerate enzyme engineering, discovery, and functional optimization. These highly adaptable platforms enable the screening of extraordinarily large and diverse protein libraries, allowing rapid identification of enzyme variants with desired catalytic properties, stability, and specificity. Our mRNA display system offers an entirely in vitro selection method capable of interrogating libraries exceeding 1012 variants, while our phage display services leverage multiple phage systems to isolate high-affinity binders in a biologically robust environment. Supported by rigorous quality control and expert-driven biopanning strategies, these services ensure consistent, high-throughput, and reliable performance. Partnering with Creative Enzymes means accessing an extensive technology toolbox designed to fulfill your enzyme engineering objectives with precision and efficiency.

Background: How Phage Display and mRNA Display Used for Enzyme Engineering

Enzyme engineering has become essential for modern biotechnology, synthetic biology, pharmaceuticals, and industrial biocatalysis. As researchers aim to enhance catalytic efficiency, substrate specificity, thermal stability, or solvent tolerance, the ability to screen vast numbers of enzyme variants rapidly and effectively is paramount. Traditional methods provide valuable insights but often fall short in handling the immense diversity required for modern protein engineering.

Display technologies—notably phage display and mRNA display—bridge this gap by linking genotype to phenotype in ways that make large-scale, high-fidelity selection possible.

Phage Display

Phage display is a powerful technique in which peptides or proteins are expressed on the surface of bacteriophages while their encoding DNA remains safely packaged within the viral particle. As a result, each displayed variant can be traced back to its genetic blueprint. This format makes iterative selection, or biopanning, particularly effective for identifying clones with high binding affinity or desirable functional characteristics. Modern phage display systems such as M13, T4, and T7 allow the construction and screening of libraries exceeding 10¹⁰ variants. Their biological resilience supports multiple rounds of enrichment without compromising fidelity.

mRNA Display

mRNA display represents a fully in vitro counterpart to phage-based systems. It links a peptide or protein directly to its mRNA through a puromycin-based covalent bond, creating a stable protein–nucleic acid fusion complex. With no cellular transformation bottlenecks, mRNA display permits the interrogation of exceptionally large libraries—often reaching 10¹² or more variants—ensuring comprehensive coverage of sequence diversity. This platform is especially valuable for selecting enzymes with subtle kinetic differences or for evolving catalytic properties that require fine-grained discrimination.

Together, phage display and mRNA display form a complementary suite of tools that overcome the limits of traditional molecular screening. Their integration into enzyme engineering pipelines boosts efficiency, precision, and throughput.

What We Offer: Phage Display and mRNA Display Services

Creative Enzymes delivers complete, end-to-end phage display and mRNA display services tailored to enzyme engineering applications. Our offerings include:

Services		Price
Pre-made library screening	Utilize our validated, high-diversity libraries for accelerated discovery without the need for custom construction.	Inquiry
Support for large library capacities	Up to >10¹⁰ variants for phage display and significantly higher for mRNA display.
High affinity selection	Achieve binding affinities in the range of 10^-7 to 10^-9, depending on target and conditions.
Multiple phage display systems	Including M13, T4, and T7, enabling flexibility in library design and display formats.
Comprehensive quality control validation	Ensures accuracy, diversity retention, and absence of biases introduced during amplification.
Minimal conformational changes in immobilized targets	We employ optimized immobilization methods to preserve the native structure of challenging targets.
Tailored biopanning strategies	Customized for affinity maturation, specificity modulation, or functional enrichment.
Enhanced panning efficiency	Increased surface area options ensure effective recovery from saturated phage solutions.
Fully customizable selection conditions	pH, temperature, cofactors, inhibitors, substrates, competitive ligands, and more.
Expert support at every stage	From project evaluation to final reporting.

Whether you require a guaranteed selection package or a flexible, custom-designed workflow, our services are designed to meet the precise needs of your project.

Phage Display Workflow

Workflow of phage display for enzyme engineering at Creative Enzymes

# Required for the guaranteed packages but optional for custom services.

Illustration of the phage display cycle Figure 1. Binding protein selection from phage display libraries. (Sidhu and Koide, 2007)

mRNA Display Workflow

Workflow of mRNA display for enzyme engineering at Creative Enzymes

# Required for the guaranteed packages but optional for custom services.

General scheme of mRNA display Figure 2. General scheme for enzyme selection by mRNA display. (Golynskiy and Seelig, 2010)

Service Details

Our display-based enzyme engineering services are available as standard or fully customized packages. Below are the core technical details included with typical projects:

Library Construction and Preparation

Custom or pre-made libraries with tunable mutation rates.
Coverage of active sites, substrate-binding pockets, or entire enzyme scaffolds.
Techniques including error-prone PCR, DNA shuffling, site-directed saturation mutagenesis, modular recombination, and more.

Selection and Screening

Optimization for affinity, catalytic turnover, specificity, or stability.
Adaptable environmental conditions, mimicking native or industrial settings.
Selection strategies for:
- positive selection
- Negative/competitive selection
- Multi-step functional selection
- Substrate analog screening
- Thermostability or solvent tolerance enrichment

Characterization of Selected Clones

Activity assays (colorimetric, fluorometric, chromatographic analyses).
Binding affinity measurement (SPR, BLI, ITC depending on requirements).
Sequencing for variant identification.
Bioinformatic assessment of sequence families, consensus motifs, and evolutionary trends.
Optional structural modeling and computational design support.

Data Reporting

Comprehensive documentation of each selection cycle.
Full sequence lists of enriched clones.
Interpretation of results, with suggestions for next-step engineering.

Contact Our Team

Why Choose Us

Exceptional Expertise in Display Technologies

Our scientists have extensive experience applying phage display and mRNA display to a wide range of enzyme families.

Industry-Leading Library Diversity

With library sizes exceeding 10¹⁰ for phage display and even larger for mRNA display, we ensure comprehensive exploration of sequence landscapes.

Rigorous Quality Control

Each step of library preparation, selection, and amplification undergoes stringent QC to maintain integrity and reduce selection bias.

Highly Customizable Workflows

Your project's goals determine our strategy. From biopanning stringency to environmental parameters and functional assays, every aspect can be tailored.

Advanced High-Throughput Screening Capabilities

Our high-throughput platforms rapidly analyze thousands of variants using cutting-edge detection and analysis tools.

Proven Track Record of Success

Creative Enzymes has implemented display-based engineering for academic, industrial, and pharmaceutical partners worldwide.

Case Studies and Real-World Insights

Case 1: Engineering Novel Enzyme Variants Using Phage Display

Phage display has become a powerful tool for engineering enzymes by enabling direct or indirect selection of variants with enhanced activity, specificity, or stability. By coupling enzymatic function to affinity-based selection—using transition-state analogues, suicide substrates, or product-forming active phage—researchers can efficiently mine large mutant libraries. These methods have produced enzymes with improved catalytic properties and facilitated the discovery of highly active catalytic antibodies. Compared with traditional mutagenesis or small-scale screening, phage display offers significantly greater library capacity and selection sensitivity, making it a robust platform for identifying enzyme variants capable of supporting advanced biotechnological applications.

Using phage display as a tool for the directed evolution of enzymes Figure 3. The phage-enzymes are initially inactivated by extracting the essential metallic cofactor and are captured with an immobilized substrate. Addition of the metallic cofactor (Zn²⁺) results in the catalytic elution of the active phage-enzyme. (Fernandez-Gacio et al., 2003)

Case 2: Engineering a Thermostable Artificial Enzyme Using mRNA Display

mRNA display was applied to simultaneously improve both activity and stability in an artificial RNA ligase. A library of mesophilic ligase variants, originally selected at ambient temperature, was re-screened under stringent conditions at 65°C. This single-step selection yielded ligase 10C, a variant not only active at high temperature but also tenfold more active at room temperature than earlier enzymes. Its melting temperature increased by 35°C, enabling structural determination by NMR and revealing a completely novel protein fold. This study demonstrates the power of mRNA display for isolating thermostable, highly active artificial enzymes with unprecedented architectures.

Isolating thermostable artificial enzymes by in vitro selection Figure 4. Activity of ligase enzymes assayed at different temperatures. Ligases #6 and #7 had been selected previously at 23°C and ligase 10C was selected at 65°C. In this assay, the ³²P-labeled PPP-substrate-65, HO-substrate-65 and 40 nt splint were incubated with the individual enzymes for 16 h and the activity was monitored by a gel-shift assay. (Morelli et al., 2014)

FAQs: Phage Display and mRNA Display Services

Q: What types of enzymes are suitable for display-based engineering?

A: Most enzyme classes—including hydrolases, oxidoreductases, ligases, transferases, and isomerases—can be adapted for phage or mRNA display. We assess your target and recommend the most suitable system.
Q: How many selection rounds are typically required?

A: Most projects require 3–6 rounds of selection. The exact number depends on library complexity, stringency, and selection goals.
Q: Can Creative Enzymes work with difficult or unstable targets?

A: Yes. Our optimized immobilization strategies minimize conformational disturbances and accommodate sensitive proteins. For extremely unstable targets, mRNA display may be preferable due to its fully in vitro nature.
Q: What information do I need to provide to start a project?

A: Basic target information, project objectives, available assay formats, and any known sequence constraints are helpful. Our team will guide you during onboarding.
Q: Are customized selection conditions available?

A: Absolutely. We can adjust pH, temperature, substrates, cofactors, inhibitors, or competitive ligands to simulate native or industrial environments.
Q: How long does a full display project take?

A: Timelines vary, typically ranging from several weeks to a few months depending on library type, number of rounds, and depth of characterization.

References:

Fernandez-Gacio A, Uguen M, Fastrez J. Phage display as a tool for the directed evolution of enzymes. Trends in Biotechnology. 2003;21(9):408-414. doi:10.1016/S0167-7799(03)00194-X
Golynskiy MV, Seelig B. De novo enzymes: from computational design to mRNA display. Trends in Biotechnology. 2010;28(7):340-345. doi:10.1016/j.tibtech.2010.04.003
Morelli A, Haugner J, Seelig B. Thermostable artificial enzyme isolated by in vitro selection. Andre I, ed. PLoS ONE. 2014;9(11):e112028. doi:10.1371/journal.pone.0112028
Sidhu SS, Koide S. Phage display for engineering and analyzing protein interaction interfaces. Current Opinion in Structural Biology. 2007;17(4):481-487. doi:10.1016/j.sbi.2007.08.007

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry